Horizon Pharma plc to Participate in UBS Global Healthcare Conference

DUBLIN, IRELAND -- (Marketwired) -- 05/18/16 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that Timothy P. Walbert, chairman, president and chief executive officer, will present at the UBS Global Healthcare Conference at 11 a.m. EDT on May 25, 2016 in New York City, NY.

The conference presentation, which will include an update of Horizon's business, will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.

About Horizon Pharma plc Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets nine medicines through its orphan, rheumatology and primary care business units. Horizon Pharma's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:

Investors:
John Thomas
Executive Vice President, Strategy & Investor Relations
[email protected]

Tina Ventura
Vice President, Investor Relations
[email protected]

U.S. Media:
Geoff Curtis
Senior Vice President, Corporate Communications
[email protected]

Ireland Media:
Ray Gordon
Gordon MRM
[email protected]

Source: Horizon Pharma plc

You May Also Be Interested In

• Borussia Dortmund GmbH & Co. KGaA: Borussia Dortmund publishes preliminary figures for the 2025/2026 financial year
• New Crypto Presale Moonberg Surpasses $300,000 as Shiba Inu Price Prediction Targets $0.0000054
• IDnow Receives Certification to Issue Qualified Electronic Attestations of Attributes (QEAAs), Closing a Key Gap in EU Compliance